Cargando…
Oral delivery of insulin /
Diabetes Mellitus, a syndrome of disordered metabolism, characterised by abnormal elevation in blood glucose level, has become a life-threatening condition for many people. Current means of therapy for Diabetes Mellitus do not mimic the normal physiological pattern of insulin release. Oral delivery...
| Clasificación: | Libro Electrónico |
|---|---|
| Autores principales: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Oxford :
Woodhead Publishing,
2014.
|
| Colección: | Woodhead Publishing series in biomedicine ;
no. 41. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Mi 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn890162866 | ||
| 003 | OCoLC | ||
| 005 | 20231120111720.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 140915s2014 enk ob 001 0 eng d | ||
| 010 | |a 2014950424 | ||
| 040 | |a UKMGB |b eng |e rda |e pn |c UKMGB |d N$T |d OPELS |d YDXCP |d CHVBK |d OCLCF |d IDEBK |d EBLCP |d OCLCQ |d CNCGM |d MERER |d OCLCQ |d OCLCO |d ITD |d OCLCO |d OCLCQ |d U3W |d D6H |d OCLCQ |d OTZ |d WYU |d LOA |d CUY |d ZCU |d USU |d MERUC |d OCLCO |d ICG |d K6U |d COCUF |d OCLCQ |d VT2 |d DKC |d FEM |d RTH |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d UKAHL |d OCLCQ |d OCLCA |d VLY |d OCLCO |d OCL |d OCLCQ |d OCLCO | ||
| 016 | 7 | |a 016869524 |2 Uk | |
| 016 | 7 | |a 016856985 |2 Uk | |
| 019 | |a 898422306 |a 968101593 |a 969047899 |a 1066443727 |a 1088966405 |a 1155227401 |a 1162430750 |a 1228608459 | ||
| 020 | |a 9781908818683 |q (electronic bk.) | ||
| 020 | |a 1908818689 |q (electronic bk.) | ||
| 020 | |z 9781907568473 |q (hbk.) | ||
| 020 | |z 1907568476 |q (print) | ||
| 035 | |a (OCoLC)890162866 |z (OCoLC)898422306 |z (OCoLC)968101593 |z (OCoLC)969047899 |z (OCoLC)1066443727 |z (OCoLC)1088966405 |z (OCoLC)1155227401 |z (OCoLC)1162430750 |z (OCoLC)1228608459 | ||
| 050 | 4 | |a RC661.I6 |b S66 2014 | |
| 060 | 4 | |a 2015 A-997 | |
| 060 | 4 | |a WK 820 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.462061 |2 23 |
| 100 | 1 | |a Sonia, Thundiparambil Azeez, |e author. | |
| 245 | 1 | 0 | |a Oral delivery of insulin / |c Thundiparambil Azeez Sonia, Chandra P. Sharma. |
| 264 | 1 | |a Oxford : |b Woodhead Publishing, |c 2014. | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |2 rda | ||
| 490 | 1 | |a Woodhead publishing series in biomedicine ; |v number 41 | |
| 588 | 0 | |a CIP data; item not viewed. | |
| 520 | |a Diabetes Mellitus, a syndrome of disordered metabolism, characterised by abnormal elevation in blood glucose level, has become a life-threatening condition for many people. Current means of therapy for Diabetes Mellitus do not mimic the normal physiological pattern of insulin release. Oral delivery is the preferred route of administration due to its non-invasive nature. Oral delivery of insulin presents an overview of Diabetes Mellitus, and discusses the strategies and techniques adopted for oral delivery of insulin. This title begins with an introductory chapter on symptoms, complications and therapy for Diabetes Mellitus. Subsequent chapters cover the various routes for administering insulin; the challenges and strategies of oral delivery; experimental techniques in the development of an oral insulin carrier; lipids; inorganic nanoparticles and polymers in oral insulin delivery; and a summary and presentation of future perspectives on oral delivery of insulin. | ||
| 505 | 0 | 0 | |g Machine generated contents note: |g 1. |t Diabetes mellitus -- an overview -- |g 1.1. |t Diabetes mellitus -- an introduction -- |g 1.2. |t Glucose homeostasis -- |g 1.3. |t Types of diabetes -- |g 1.4. |t Symptoms of diabetes -- |g 1.5. |t Complications of diabetes -- |g 1.6. |t Diagnosis of diabetes mellitus -- |g 1.7. |t Therapy for diabetes -- |g 1.8. |t Non-insulin treatment options of type 1 diabetes -- |g 1.9. |t Treatment options of type 2 diabetes -- |g 1.10. |t Conclusion -- |g 1.11. |t References -- |g 2. |t Routes of administration of insulin -- |g 2.1. |t Current approach for the delivery of insulin -- |g 2.2. |t Routes of administration of insulin -- |g 2.3. |t Conclusion -- |g 2.4. |t References -- |g 3. |t Oral insulin delivery -- challenges and strategies -- |g 3.1. |t Oral delivery of insulin -- |g 3.2. |t Barriers to oral delivery of insulin -- |g 3.3. |t Strategies and alternatives to improve oral insulin delivery -- |g 3.4. |t Conclusion -- |g 3.5. |t References -- |g 4. |t Experimental techniques involved in the development of oral Insulin carriers -- |g 4.1. |t Introduction -- |g 4.2. |t Polymeric nanoparticles -- |g 4.3. |t Physicochemical characterization of nanoparticles -- |g 4.4. |t Biological evaluation -- |g 4.5. |t In vitro method for assessing drug permeability -- |g 4.6. |t In vivo study of oral insulin -- |g 4.7. |t Biodistribution studies -- |g 4.8. |t Conclusion -- |g 4.9. |t References -- |g 5. |t Lipids and inorganic nanoparticles in oral insulin delivery -- |g 5.1. |t Lipid-based systems for oral delivery of insulin -- |g 5.2. |t Liposomes -- |g 5.3. |t Solid lipid nanoparticles -- |g 5.4. |t Nanostructured lipid carriers -- |g 5.5. |t Niosomes -- |g 5.6. |t Archaeosomes -- |g 5.7. |t Cubic nanoparticles (cubosomes) -- |g 5.8. |t Aquasomes -- |g 5.9. |t Inorganic nanoparticles as carriers for oral insulin delivery -- |g 5.10. |t Conclusion -- |g 5.11. |t References -- |g 6. |t Polymers in oral insulin delivery -- |g 6.1. |t Introduction -- |g 6.2. |t Characteristics of an ideal oral insulin carrier -- |g 6.3. |t Polymers in oral insulin delivery -- |g 6.4. |t Natural polymers -- |g 6.5. |t Synthetic polymers -- |g 6.6. |t Conclusion -- |g 6.7. |t References -- |g 7. |t Summary and future perspectives for oral insulin delivery -- |g 7.1. |t Introduction -- |g 7.2. |t Technologies developed for clinical applications of oral insulin delivery -- |g 7.3. |t Conclusions and future perspectives -- |g 7.4. |t References. |
| 504 | |a Includes bibliographical references and index. | ||
| 546 | |a English. | ||
| 650 | 0 | |a Insulin |x Therapeutic use |x Administration. | |
| 650 | 0 | |a Diabetes |x Oral therapy. | |
| 650 | 0 | |a Oral medication. | |
| 650 | 1 | 2 | |a Insulin |x administration & dosage |0 (DNLM)D007328Q000008 |
| 650 | 1 | 2 | |a Administration, Oral |0 (DNLM)D000284 |
| 650 | 2 | 2 | |a Drug Delivery Systems |0 (DNLM)D016503 |
| 650 | 2 | |a Hypoglycemic Agents |0 (DNLM)D007004 | |
| 650 | 6 | |a Insuline |x Administration. |0 (CaQQLa)201-0268407 | |
| 650 | 6 | |a Hypoglyc�emiants. |0 (CaQQLa)201-0022942 | |
| 650 | 6 | |a M�edicaments |x Administration par voie orale. |0 (CaQQLa)201-0111888 | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Oral medication |2 fast |0 (OCoLC)fst01047087 | |
| 650 | 7 | |a Diabetes |x Oral therapy |2 fast |0 (OCoLC)fst00892178 | |
| 650 | 7 | |a Insulin |x Therapeutic use |x Administration |2 fast |0 (OCoLC)fst00974518 | |
| 700 | 1 | |a Sharma, Chandra P., |e author. | |
| 776 | 0 | 8 | |i Print version: |a Sharma, C.P. |t Oral delivery of insulin. |d Cambridge : Woodhead, 2014 |z 9781907568473 |w (DLC) 2014950424 |w (OCoLC)876802531 |
| 830 | 0 | |a Woodhead Publishing series in biomedicine ; |v no. 41. |x 2050-0289 | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9781907568473 |z Texto completo |